EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of systemic immune‐inflammation index with high risk for prostate cancer in middle‐aged and older US males: A population‐based study

Wentao Yao, Jiacheng Wu, Ying Kong, Feng Xu, Yinyi Zhou, Qing Sun, Qingqing Gao, Zhenyu Cai, Chendi Yang, Yuhua Huang iD

Immunity, Inflammation and Disease · 2024-06 · 12 (6)

DOI: 10.1002/iid3.1327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 24.06.2024. Verfasst von Wentao Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Soochow University, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Inflammation, Prostate-Specific Antigen, Nutrition Surveys. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Key Research and Development Program of Jiangsu Province, The Science and Technology Project of Suzhou City of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic immune‐inflammation index (SII) provides convincing evaluation of systemic immune and inflammatory condition in human body. Its correlation with prostate cancer (PCa) risk remains uncharted. The principal objective of this investigation was to elucidate the association between SII and the risk for PCa in middle‐aged and elderly males. Materials and Methods Analysis entailed multivariate linear and logistic regression, generalized additive model, and smoothing curve fitting using resource from 2007 to 2010 National Health and Nutrition Examination Survey (NHANES). To ascertain robustness and consistency of this association across different demographic strata, we conducted rigorous subgroup analyses and interaction tests.

Results

Among 3359 participants, those with elevated SII displayed higher total prostate‐specific antigen (tPSA) levels, higher risk for PCa, and lower free/total PSA (f/t PSA) ratio. Specifically, each unit increase of log 2 (SII) was associated with a 0.22 ng/mL increase in tPSA (β: 0.22, 95% confidence intervals [CI] 0.05–0.38), a 2.22% decline in f/t PSA ratio (β: −2.22, 95% CI −3.20 to −1.23), and a 52% increased odds of being at high risk for PCa (odds ratio [OR]: 1.52, 95% CI 1.13–2.04). People in the top quartile of log 2 (SII) exhibited 0.55 ng/mL increased tPSA (β: 0.55, 95% CI 0.19–0.90), 4.39% reduced f/t PSA ratio (β: −4.39, 95% CI −6.50 to −2.27), and 168% increased odds of being at high risk for PCa (OR: 2.68, 95% CI 1.32–5.46) compared to those in the bottom quartile.

Conclusion

Systemic immune and inflammatory condition, as represented by SII, is independently and positively associated with tPSA levels and the risk for PCa, as well as independently and negatively associated with f/t PSA ratio among middle‐aged and older US males. These findings may enhance the effectiveness of PCa screening in predicting positive biopsy results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsInflammationProstate-Specific AntigenNutrition SurveysHumansMaleMiddle AgedAgedUnited StatesRisk Factors

Stichwörter der Autor:innen

NHANESmiddle‐aged and older malesprostate cancerprostate‐specific antigensystemic immune‐inflammation index

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Soochow University, China.
  • Department of Urology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, China.
  • Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, China.
  • Department of Preventive Medicine, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, China.

ORCID-Profile: Yuhua Huang

Förderung

  • The Key Research and Development Program of Jiangsu Province
  • The Science and Technology Project of Suzhou City of China

Zitieren

APA

Yao, W., Wu, J., Kong, Y., Xu, F., Zhou, Y., Sun, Q., Gao, Q., Cai, Z., Yang, C., & Huang, Y. (2024). Associations of systemic immune‐inflammation index with high risk for prostate cancer in middle‐aged and older US males: A population‐based study. Immunity, Inflammation and Disease, 12(6). https://doi.org/10.1002/iid3.1327

Vancouver

Yao W, Wu J, Kong Y, Xu F, Zhou Y, Sun Q, et al. Associations of systemic immune‐inflammation index with high risk for prostate cancer in middle‐aged and older US males: A population‐based study. Immunity, Inflammation and Disease. 2024;12(6). doi:10.1002/iid3.1327

BibTeX
@article{Yao2024,
  author = {Yao, Wentao and Wu, Jiacheng and Kong, Ying and Xu, Feng and Zhou, Yinyi and Sun, Qing and Gao, Qingqing and Cai, Zhenyu and Yang, Chendi and Huang, Yuhua},
  title = {Associations of systemic immune‐inflammation index with high risk for prostate cancer in middle‐aged and older US males: A population‐based study},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  volume = {12},
  number = {6},
  doi = {10.1002/iid3.1327}
}
Kostenlos starten →